SEC Form 4/A · accession 0001716950-18-000012
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Matthew Feinsod
Officer — Interim Chief Medical Officer
Period of report
Feb 9, 2018
Accepted (ET)
Apr 6, 2018 · 8:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001273636
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Feb 9, 2018 | A | 2,000 | $0.00 | A | 27,462 | D | |
| Common StockF4 | Feb 9, 2018 | F | 733 | $3.95 | D | 26,729 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4/A amends the Form 4 previously filed on February 13, 2018 (the "February Form 4") in order to correct the transaction date from February 11, 2018 to February 9, 2018.
- F2The common stock vested immediately upon grant.
- F3Such number has been updated to reflect a Form 4 and a Form 4/A, each filed on the date hereof. The Form 4 reported the number of shares withheld in connection with the reporting person's tax obligation as a result of the vesting of a restricted stock award on December 11, 2017. The Form 4/A amended a Form 4 filed on January 16, 2018 to correct the number of shares withheld in connection with the reporting person's tax obligation as a result of a fully vested stock award.
- F4This Form 4/A amends the February Form 4 to report the number of shares withheld in connection with the reporting person's tax obligation with respect to the fully vested stock award.